To address the potential selectivity of HA-CPNs towards glioma populations characterized by CD44 expression, U-251 MG cells were incubated with increasing concentrations of HA-CPNs for 48 h followed by staining with a fluorescent anti-CD44 antibody. Here, CD44 is linked to glioma.